4.7 Article

Humoral and cellular correlates of a novel immune-related adverse event and its treatment

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Oncology

Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immune checkpoint inhibitor-related adverse events

Julie R. Brahmer et al.

Summary: ICIs are standard treatments for cancer, but come with risks of immune-related adverse events. The SITC convened an expert panel to develop guidelines for managing irAEs, aiming to improve patient outcomes through evidence-based recommendations.

JOURNAL FOR IMMUNOTHERAPY OF CANCER (2021)

Article Oncology

Immune dysregulation in cancer patients developing immune-related adverse events

Shaheen Khan et al.

BRITISH JOURNAL OF CANCER (2019)

Article Ophthalmology

Ocular adverse events with immune checkpoint inhibitors

Tony Fang et al.

JOURNAL OF CURRENT OPHTHALMOLOGY (2019)

Article Oncology

Clinical assessment of immune-related adverse events

Aaron Sosa et al.

THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY (2018)

Review Biotechnology & Applied Microbiology

Ipilimumab in the treatment of metastatic melanoma: management of adverse events

Giuseppina Della Vittoria Scarpati et al.

ONCOTARGETS AND THERAPY (2014)

Review Immunology

Standardizing immunophenotyping for the Human Immunology Project

Holden T. Maecker et al.

NATURE REVIEWS IMMUNOLOGY (2012)

Article Biochemical Research Methods

Genesis: cluster analysis of microarray data

A Sturn et al.

BIOINFORMATICS (2002)